Trial reportPloS one2025
Effects of boysenberry on postprandial energy metabolism in healthy adults: A randomized controlled crossover trial.
Trial report in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trial
- The context-dependent roles of PPAR-γ in adipocyte differentiation and obesity: a master regulator with dual functions.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brown adipose tissue (BAT) is essential for thermoregulation and energy metabolism, converting fatty acids into thermal energy in response to cold exposure and dietary intake, thereby contributing to both cold-induced thermogenesis and diet-induced thermogenesis (DIT). Our previous research suggests that boysenberry anthocyanins (BoyACs) may activate BAT under cold conditions, and we hypothesized that BoyACs could also influence DIT through the activation of BAT. This pilot randomized, double-blind crossover trial aimed to evaluate the effects of daily intake of BoyACs on DIT in healthy adults (registration number: UMIN000047413). Twenty-two participants consumed either a boysenberry juice (BoyJ) beverage containing 61.0 mg of BoyACs or a placebo beverage daily for four weeks, with a four-week washout period separating the two interventions. Three participants withdrew during the trial, resulting in data from 19 participants being analyzed. Results showed no significant changes in DIT, defined as increase in postprandial energy expenditure, or skin temperature of BAT regions. However, a significant increase in postprandial fat oxidation was observed. No significant differences were observed in other outcomes. These results suggest that BoyJ intake does not significantly affect postprandial energy expenditure but may influence substrate utilization to promote fat oxidation. Further studies focusing on substrate utilization, particularly fat oxidation, as the primary outcome are necessary to confirm these results and fully understand the implications of BoyJ intake on energy metabolism.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.